Delinea, a leading provider of privileged access management (PAM) solutions for seamless security, today announced it has been positioned by Gartner, Inc. in the Leaders Quadrant of the 2022 Gartner Magic Quadrant for Privileged Access Management. The report evaluated 11 vendors based on completeness of vision and ability to execute.
Delinea was formed in April 2021 after TPG Global acquired and merged Centrify and Thycotic. Centrify was previously named a Leader in the 2018, 2020, and 2021 Gartner Magic Quadrant for Privileged Access Management reports. Thycotic was also named a Leader in the 2020 and 2021 Gartner Magic Quadrant for Privileged Access Management reports. This is the fourth consecutive time Delinea has been recognized as a Leader.
“We are thrilled that Delinea has been recognized as a Leader in the 2022 Gartner Magic Quadrant for Privileged Access Management,” said Art Gilliland, CEO, Delinea. “We believe this recognition reinforces our commitment to seamless usability while reinforcing best practices such as least privilege and zero standing privileges. Furthermore, we believe the recognition acknowledges the successes Delinea has earned since merging two of the PAM Leaders last year to become a stronger partner to our customers, with a more comprehensive solutions portfolio delivered as SaaS or on-premises.”
As organizations face growing threats including ransomware, data breaches, insider attacks, and more, Delinea believes that placing strict controls on privileged accounts and access is required now more than ever. Delinea puts privileged access at the center of cybersecurity for the modern, hybrid enterprise by granting access to critical data, devices, code, and cloud infrastructure using a centralized dashboard. With Delinea, the boundaries of access are easily defined to help customers reduce risk, ensure compliance, and streamline security.
Get complimentary access to the report to learn more about evaluations by Gartner: https://delinea.com/resources/gartner-magic-quadrant-pam. For more information about Delinea, visit delinea.com.